Aktis Oncology, Inc. (AKTS)
18.15
+0.41
(+2.31%)
USD |
NASDAQ |
Oct 09, 16:00
18.14
-0.02
(-0.08%)
After-Hours: 20:00
Aktis Oncology Total Assets (Quarterly) : 557.60M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 557.60M |
| March 31, 2026 | 576.80M |
| December 31, 2025 | 270.01M |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 331.23M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 72.76M |
| Shareholders Equity (Quarterly) | 484.84M |
| Debt to Equity Ratio | 0.0232 |
| Current Ratio | 16.33 |
| Net Debt Paydown Yield | 0.01% |